Today: 29 April 2026
Hudson Pacific Properties stock jumps on 2026 outlook reset — what to watch before the bell
27 February 2026
2 mins read

Hudson Pacific Properties stock jumps on 2026 outlook reset — what to watch before the bell

New York, Feb 27, 2026, 08:28 ET — Premarket

Key points:

  • Hudson Pacific Properties soared 20.9% Thursday, following its release of a 2026 funds-from-operations outlook.
  • The company posted a sharp net loss for the quarter, hit by a non-cash impairment related to its Quixote business along with several other factors.
  • Leasing updates, debt maturities, and REITs’ sensitivity to rates are drawing traders’ attention ahead of the U.S. inflation numbers, which hit at 8:30 a.m. ET.

Hudson Pacific Properties Inc jumped in after-hours trading Thursday, with shares recently at $7.70. The office-and-studio landlord brought back its full-year outlook and highlighted new leasing activity.

Why does it matter? Hudson Pacific’s stock has been acting like a balance-sheet bet. Office REITs have taken hits from investors worried about vacancy rates and refinancing pressure. Now, the company is working to prove it’s got enough runway and a route back to more reliable cash flow.

This comes at a tricky time for rate-sensitive real estate stocks. Swings in inflation data and bond yields are steering the mood, so even when a company sees a pop, rallies can evaporate quickly if rates jump.

Hudson Pacific swung to a net loss of $277.9 million, or $4.31 a share, for the fourth quarter, the company said late Thursday. The numbers reflect a non-cash, non-real-estate impairment charge on Quixote. Total revenue came in at $256.0 million, with results getting a boost from a lease termination fee following the sale of the Element LA office campus.

The company posted FFO excluding certain items at $13.6 million, translating to $0.21 per diluted share. FFO—funds from operations—serves as a key REIT metric, adjusting for property depreciation and a handful of unusual items to give a clearer read on operations.

Hudson Pacific put out its FFO guidance for 2026, projecting $0.96 to $1.06 per diluted share, the company said in its release. No specific items are included in that range.

Hudson Pacific offloaded Element LA for $150 million and landed an additional $81 million from a lease termination. The company applied the net proceeds to pay down $206 million in commercial mortgage-backed securities tied to the site, with leftover funds earmarked for general corporate use.

The company closed out the year with $933.6 million in total liquidity and no debt maturities looming until the third quarter of 2026. Office occupancy at quarter end came in at 76.3%, with leasing reaching 77.0%. Over the past 12 months, in-service studio portfolio and stages posted leasing rates of 67.1% and 69.1%, respectively.

On the earnings call, executives stuck to their “runway” narrative. CFO Harout Krikor Diramerian told analysts the team is working toward a fix for the Collared Media portfolio before its August 2026 maturity, and said Hudson Pacific is “fully engaged with Netflix” on the Los Angeles office portfolio linked to that partnership. https://www.fool.com/earnings/call-transcr…

Still, there’s turbulence ahead. Management expects same-store property cash net operating income—a measure of property-level earnings before financing—to fall in 2026. On the call, executives pointed to lingering uncertainty for what they’re referring to as “Coyote,” saying more write-downs could be on the table if the business doesn’t improve. https://www.fool.com/earnings/call-transcr…

Hudson Pacific put out its latest quarterly press release and supplemental operating package in a Form 8-K, dated Feb. 26, according to a filing.

REIT traders now have their eyes on the U.S. producer price index print for January, set for 8:30 a.m. ET — it’s one of the main numbers feeding into rate bets. Then comes the February jobs report, landing March 6, another possible catalyst for volatility in yields.

Stock Market Today

  • S&P 500 Futures Gain as Investors Await Federal Reserve Decision
    April 29, 2026, 7:37 AM EDT. US stock futures edged higher with the E-mini S&P 500 and Nasdaq 100 up ahead of the Federal Reserve's April meeting, where rates are expected to hold steady. The 10-year Treasury yield hovered near 4.35%, and falling oil inventories pressured energy costs. Key sectors like housing, banks, and growth stocks face challenges amid sustained higher borrowing costs. Centene surged nearly 14% following an analyst upgrade, while Revolution Medicines and AvalonBay Communities also climbed. Major earnings from tech giants Alphabet, Microsoft, and Meta, as well as healthcare and financials, are due in the coming sessions, setting the tone for growth and spending trends. Investors are advised to monitor resilient stocks with low risk amid market volatility.

Latest article

Dogecoin’s Latest Move Has Traders Watching One Risk That Could Flip The Rally

Dogecoin’s Latest Move Has Traders Watching One Risk That Could Flip The Rally

29 April 2026
Dogecoin surged 10.9% to $0.1101 in 24-hour trading Wednesday, breaking above $0.10 with $2.91 billion in volume, according to CoinGecko. Meme-token presales Pepeto and AlphaPepe cited the rally to promote early-stage listings, but their claims remain unverified. Rising futures open interest has increased the risk of a sharp reversal if leveraged longs exit. Dogecoin’s market cap reached about $16.9 billion.
SoFi Stock Gets Its Q1 Verdict: Record Revenue, Bigger Loans, One Weak Spot

SoFi Stock Gets Its Q1 Verdict: Record Revenue, Bigger Loans, One Weak Spot

29 April 2026
SoFi Technologies reported first-quarter adjusted net revenue up 41% to $1.087 billion, beating estimates, with net income more than doubling to $166.7 million. Lending originations jumped 68% to $12.18 billion, while deposits rose to $40.2 billion. Technology Platform revenue dropped 27% after a major client exit. SoFi began minting SoFiUSD, a dollar-backed stablecoin, and expanded digital asset efforts.
CRISPR Therapeutics stock whipsaws again as takeover talk resurfaces — here’s what to watch
Previous Story

CRISPR Therapeutics stock whipsaws again as takeover talk resurfaces — here’s what to watch

GRAIL stock dips in premarket after a sharp bounce as Galleri trial fallout hangs over GRAL
Next Story

GRAIL stock dips in premarket after a sharp bounce as Galleri trial fallout hangs over GRAL

Go toTop